Past Trials

AFFINITY

Assessment of fluoxetine in stroke recovery trial Lead PI:  Prof Graeme J Hankey and A/Prof Maree L. Hackett Status: Closed No….

ASSENT

A Phase 1b/2, Multi-Centre, Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in…

AVERT

A Very Early Rehabilitation Trial AVERT is a Phase III, international, multicentre, single blind trial comparing earlier onset and higher…

COMPARE

Constraint Induced or Multi-Modal aphasia rehabilitation: A Randomised Controlled Trial (RCT) for stroke related chronic aphasia Lead PI: A/Prof Miranda Rose Status: Completed…

ESCAPE NA-1

A Multicentre, Randomised, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects…

EXTEND

Extending the time for Thrombolysis in Emergency Neurological Deficits Phase III, randomised, multicentre, double blinded, placebo controlled trial (2 arm…

EXTEND-IA TNK

Extending the time for thrombolysis in emergency neurological deficits – intra-arterial with tenecteplase Lead PI: Dr Bruce Campbell Status: Closed  No. of…

INSPIRE

INternational Stroke Perfusion Imaging Registry INSPIRE: INternational Stroke Perfusion Imaging REgistry Lead PI:  John Hunter Hospital Status: Closed No. of Patients…

ReMEDY

A Randomised, Double Blind, Placebo-controlled Phase II Multicentre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and…

1 2